Platelets play an important role in atherothrombotic disease. The currently available antiplatelet drugs target key steps of platelet activation including thromboxane A 2 synthesis, ADP-mediated ...

—These findings suggest that a shorter duration of antiplatelet therapy may be a safe and effective strategy for these patients, but further research is needed to confirm these findings and ...

Background: Stroke is the leading cause of disability globally, with antiplatelet therapy being crucial for secondary prevention but also increasing bleeding risks. This requires careful dosage ...

Background While dual antiplatelet therapy (dAPT) is standard of care following carotid artery stenting (CAS), the optimal dAPT regimen and duration has not been established. Methods We canvassed a ...

The following is a summary of “Antiplatelet therapy is not associated with increased risk of complications after lumbar ...

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Y.Z., X.W., Y.G., W.C., H.Y., T.W., Y.Y., Q.Z., M.W., J.J., C.W., Yongjun Wang ...

The risk for recurrent cardiovascular events is high among patients with r-axSpA and a history of these events, though TNF inhibitor therapy may offer protective benefits.

Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, PR China University of Chinese Academy of Sciences, Beijing 100049, PR China Technical Institute of Physics ...

The ARIES-HM3 trial analysis found that in advanced heart failure patients with traditional indications for antiplatelet ...

Highlighted text has been updated as of December 20, 2024. The HOST-EXAM trial showed that clopidogrel monotherapy is superior to aspirin monotherapy as chronic maintenance therapy among patients who ...